by Mybiogate | Dec 23, 2020 | Interview
Authors: Ziyi Xu, Chun Chen Editor: Ginger Ding In the 11 years from its debut in 2009 to its IPO on the Hong Kong Stock Exchange in 2020, Kintor Pharmaceutical has had 5 clinical-stage products under development and carried out multiple phase I-III clinical... 
by Mybiogate | Oct 8, 2020 | Interview
Authors: Suzanne Ferguson The Covid-19 pandemic highlights the critical need for governments and industry to take immediate action to promote faster and more scalable manufacturing platforms, which will require developing cell lines and expression systems that... 
by Mybiogate | Oct 1, 2020 | Interview
Authors: MJ Yuan, Ziyi Xu Editor: Ginger Woman leaders are filling more and more high-level roles in the business world. Long flattered as the “fairer sex” but not expected to achieve, women have proven time and again that they are just as capable as men, using their... 
by Mybiogate | Sep 11, 2020 | Interview
Author: Xu Ziyi Editor: Ginger Ding In the first half of this year, in addition to new coronavirus-related drugs and vaccines, biotech investors have enthusiastically sought after exosomes. In June 2020, large pharmaceutical companies, such as Takeda... 
by Mybiogate | Sep 10, 2020 | Interview
Author: Xu Ziyi Editor: Ginger Ding At the beginning of 2019, a story initially reported by Jerusalem Post and picked up by Forbes and other major international news outlets was making the rounds. The headlines read “An Israeli Company Claims That They... 
by Mybiogate | Sep 10, 2020 | Interview
Author: Xu Ziyi Editor: Ginger Ding For many parents, there is an image of their child in their mind. This child is one who runs carefree, their youth and exuberance frozen in their parents’ memories. For some parents, this sort of happy memory is one that they hold...